Завершено
Фаза III
Беларусь
Каталог · ЕАЭС
Клинические исследования и проекты
Ревматология · Celgene International Sarl · найдено 2
2 исследования
Завершено
Фаза III
Беларусь
ЛЕНАЛИДОМИД · Celgene International Sarl
A Phase III, Multicentre, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Parallel Group Study To Determine The Efficacy And Safety Of Lenalidomde (Revlimid®) In Combination With Melphalan And Prednisone Versus Placebo Plus Melphalan And Prednisone In Subjects With Newly Diagnosed Multiple Myeloma Who Are 65 Years Of Age Or Older